News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,240 Results
Type
Article (39416)
Company Profile (306)
Press Release (648518)
Section
Business (204778)
Career Advice (2001)
Deals (35474)
Drug Delivery (87)
Drug Development (80993)
Employer Resources (168)
FDA (16116)
Job Trends (14857)
News (345800)
Policy (32546)
Tag
Academia (2548)
Alliances (49418)
Alzheimer's disease (1233)
Approvals (16047)
Artificial intelligence (128)
Bankruptcy (354)
Best Places to Work (11555)
Biotechnology (217)
Breast cancer (119)
Cancer (1069)
Cardiovascular disease (97)
Career advice (1670)
Cell therapy (232)
Clinical research (64338)
Collaboration (379)
Compensation (195)
COVID-19 (2545)
C-suite (94)
Data (1110)
Diabetes (153)
Diagnostics (6156)
Earnings (84938)
Employer resources (146)
Events (109929)
Executive appointments (300)
FDA (16642)
Funding (347)
Gene therapy (176)
GLP-1 (578)
Government (4337)
Healthcare (18688)
Infectious disease (2629)
Inflammatory bowel disease (110)
Interviews (308)
IPO (16324)
Job creations (3658)
Job search strategy (1428)
Layoffs (417)
Legal (7888)
Lung cancer (169)
Manufacturing (175)
Medical device (13183)
Medtech (13188)
Mergers & acquisitions (19214)
Metabolic disorders (399)
Neuroscience (1506)
NextGen Class of 2024 (6534)
Non-profit (4476)
Northern California (1468)
Obesity (227)
Opinion (183)
Patents (101)
People (56569)
Phase I (19996)
Phase II (28344)
Phase III (21124)
Pipeline (452)
Postmarket research (2554)
Preclinical (8516)
Radiopharmaceuticals (235)
Rare diseases (217)
Real estate (5935)
Regulatory (21580)
Research institute (2315)
Resumes & cover letters (350)
Southern California (1293)
Startups (3613)
United States (13350)
Vaccines (550)
Weight loss (167)
Date
Today (156)
Last 7 days (876)
Last 30 days (3744)
Last 365 days (35705)
2024 (32600)
2023 (40177)
2022 (51287)
2021 (55836)
2020 (54157)
2019 (46644)
2018 (35124)
2017 (32222)
2016 (31629)
2015 (37707)
2014 (31455)
2013 (26499)
2012 (28770)
2011 (29427)
2010 (27525)
Location
Africa (716)
Arizona (191)
Asia (37316)
Australia (6105)
California (3303)
Canada (1274)
China (245)
Colorado (144)
Connecticut (150)
Europe (79975)
Florida (449)
Georgia (115)
Illinois (341)
Indiana (195)
Kansas (97)
Maryland (573)
Massachusetts (2582)
Michigan (153)
Minnesota (270)
New Jersey (944)
New York (946)
North Carolina (697)
Northern California (1468)
Ohio (139)
Pennsylvania (837)
South America (1094)
Southern California (1293)
Texas (456)
Utah (89)
Washington State (356)
688,240 Results for "mbx biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
MBX Biosciences Appoints Salomon Azoulay, M.D., as Chief Medical Officer
MBX Biosciences, Inc. today announced the appointment of Salomon (Sam) Azoulay, M.D, as Chief Medical Officer (CMO).
June 25, 2024
·
3 min read
Press Releases
MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia
November 19, 2024
·
6 min read
Press Releases
MBX Biosciences to Participate in Upcoming November Investor Conferences
October 28, 2024
·
2 min read
IPO
MBX Unveils Plans for Nasdaq Debut, Joins Two Other IPO Hopefuls
MBX Biosciences follows Bicara Therapeutics and Zenas Biopharma, which also announced last week their respective plans to go public in a potential boost to the recent slump in the IPO market.
August 26, 2024
·
2 min read
·
Tristan Manalac
Press Releases
MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
November 8, 2024
·
10 min read
Drug Development
MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting
September 30, 2024
·
8 min read
Business
MBX Biosciences Announces Pricing of Initial Public Offering
September 12, 2024
·
4 min read
Press Releases
MBX Biosciences Announces Launch of Initial Public Offering
September 9, 2024
·
5 min read
Press Releases
MBX Biosciences Doses First Patient in Phase 2 Avail™ Trial of MBX 2109 for the Treatment of Hypoparathyroidism
August 12, 2024
·
5 min read
Business
MBX Biosciences Appoints Steven Ryder, M.D., to Board of Directors
MBX Biosciences, Inc. today announced the appointment of Steven Ryder, M.D., Chief Medical Officer of Rallybio, to its Board of Directors.
February 5, 2024
·
3 min read
1 of 68,824
Next
